Clinical Trial Update: Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Ozurdex (dexamethasone intravitreal implant), ranibizumab, and their combination for macular edema due to central retinal vei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Valley Retina Institute | Conditions: Macular Edema, Central Retinal Vein Occlusion | Phase 4 | Status: UNKNOWN